Eton climbs on receiving US patent for oral steroid medicine formulation

Eton Pharmaceuticals

21/02/2024 15:17

** Shares of drug developer Eton Pharmaceuticals  ETON.O 
rise ~2% to $4.44
    ** Co says it has been awarded a U.S. patent for its
formulation of oral liquid hydrocortisone 
    ** Says the patent will expire in 2043 
    ** Hydrocortisone is a steroid medicine that calms down the
body's immune response to reduce pain, itching and swelling.
    ** Including session move, stock up nearly 30% in the last
12 months

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))